Your browser doesn't support javascript.
loading
Potential pathogenic germline variant reporting from tumor comprehensive genomic profiling complements classic approaches to germline testing.
Tung, Nadine; Dougherty, Kali Chatham; Gatof, Emily Stern; DeLeonardis, Kim; Hogan, Lauren; Tukachinsky, Hanna; Gornstein, Erica; Oxnard, Geoffrey R; McGregor, Kimberly; Keller, Rachel B.
Affiliation
  • Tung N; Department of Medical Oncology, Beth Israel Deaconess Medical Center, Boston, MA, USA.
  • Dougherty KC; Foundation Medicine, Inc., Cambridge, MA, USA.
  • Gatof ES; Department of Medical Oncology, Beth Israel Deaconess Medical Center, Boston, MA, USA.
  • DeLeonardis K; Department of Medical Oncology, Beth Israel Deaconess Medical Center, Boston, MA, USA.
  • Hogan L; Department of Medical Oncology, Beth Israel Deaconess Medical Center, Boston, MA, USA.
  • Tukachinsky H; Foundation Medicine, Inc., Cambridge, MA, USA.
  • Gornstein E; Foundation Medicine, Inc., Cambridge, MA, USA.
  • Oxnard GR; Foundation Medicine, Inc., Cambridge, MA, USA.
  • McGregor K; Foundation Medicine, Inc., Cambridge, MA, USA.
  • Keller RB; Foundation Medicine, Inc., Cambridge, MA, USA. rkeller@foundationmedicine.com.
NPJ Precis Oncol ; 7(1): 76, 2023 Aug 11.
Article in En | MEDLINE | ID: mdl-37568048
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Type of study: Guideline / Prognostic_studies Language: En Journal: NPJ Precis Oncol Year: 2023 Type: Article Affiliation country: United States
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Type of study: Guideline / Prognostic_studies Language: En Journal: NPJ Precis Oncol Year: 2023 Type: Article Affiliation country: United States